Xilio Therapeutics, Inc.XLONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-95.92%
↑ 34% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-144.31%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -95.92% | +89.5% |
| 2024 | -914.27% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |